Rupatadine Fumarate
-
API Product :
Rupatadine Fumarate
-
CEP :
-
-
WCC :
-
-
Therapeutic Use :
Systemic Antihistamines; Anti-asthma and COPD Products
-
Originator :
Pediapharm
-
CAS No. :
158876-82-5
-
Trade Name. :
Rupafin
-
Molecular Weight :
415.958 g/mol
-
Molecular Formula :
C26H26ClN3
Application
Rupatadine fumarate has been approved for the treatment of allergic rhinitis and chronic urticaria in adults and children over 12 years. It is available as round, light salmon coloured tablets containing 10 mg of rupatadine (as fumarate) to be administered orally, once a day.
General Description
Rupatadine is a second generation antihistamine and PAF antagonist used to treat allergies. It was discovered and developed by J. Uriach y Cia[1] and is marketed as Rupafin and under several other trade names.